Picard Medical Names Richard Fang Permanent CEO; Discloses $1.2M in Related-Party Loans
PMI has more than doubled off its 52-week low of $2.652 on light trading volume (0.1× avg).
Summary
Picard Medical made interim CEO Richard Fang permanent and disclosed $1.2M of loans from entities he controls, including $0.5M in 0% notes now due because the company failed to raise the $1.0M of outside funding that would have extended them.
Key Events · Executive and Board Changes · PMI
-
Fang Named Permanent CEO
Richard Fang, Ph.D. was appointed full-time CEO effective October 28, 2026, after serving as Interim CEO since June 18, 2026; he remains Chairman of the Board.
-
No Change to CEO Compensation
Fang's annual salary remains $0.4 million, and the appointment involved no new or amended compensation arrangement and no additional award.
-
$1.2M in Related-Party Loans
The company owes $0.7 million at 6% to Fang Family Fund I, LLC due February 28, 2027, plus $0.5 million in 0% loans from Fang Family Fund, LLC - Series II issued across five agreements between July 29 and October 16, 2026.
-
0% Loans Now Due After Funding Trigger Lapses
Each 0% loan came due in full if the company did not receive at least $1.0 million of external funding within two months; as of October 29, 2026 no such funding had arrived, so the earliest loans are payable on terms to be determined.
Analysis · PMI · Industrial Applications And Services
Fang's move from interim to permanent CEO leaves his $0.4M salary unchanged and carries no new equity award, making the appointment a stabilization step rather than a compensation event. More consequential is the related-party borrowing: $0.7M at 6% from an entity he controls, plus $0.5M in 0% loans from a second Fang-affiliated fund. Those 0% loans were to be repaid once Picard raised at least $1.0M externally within two months of each deposit; the company confirms no such funding has arrived, so the earliest loans are already due on terms still to be determined. That is a liquidity squeeze disclosed in a governance filing, and it puts the CEO on both sides of the company's short-term funding.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PMI was trading at $7.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $19.1M. The 52-week trading range was $2.65 to $684.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.